Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023
Health Expectations · 2025
DOI: 10.1111/hex.70273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Expectations, 2025. Verfasst von Essa Tawfiq und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biosecurity Program, The Kirby Institute, Faculty of Medicine and Health, The University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: E.T., R.C., D.A.H., R.D., M.K., A.N. and D.G. are supported by the Balvi Filantropic Fund. C.R.M. is funded by NHMRC Investigator Grant 2016907. D.A.H. and A.N….
Abstract (Originalsprache)
Background
Limited data exists regarding long Covid burden following Omicron infection in highly vaccinated populations.
Objective
To (1) characterise long Covid prevalence and predictors and (2) identify key symptom clusters and their correlates among long Covid patients, during an Omicron‐predominant period in a highly vaccinated population.
Design
Anonymous, online, cross‐sectional survey.
Setting
January 2023, Australia.
Participants
Residents aged ≥ 18 years with self‐reported history of test‐positive Covid‐19. The main variables studied were socio‐demographic characteristics, Covid‐19 risk factors, vaccination, infection history and experiences with long Covid. Main Outcome Measures Long Covid symptoms. Symptom‐based clustering was used to identify long Covid symptom clusters and their functional correlates. Predictors of long Covid occurrence and severity were assessed using multivariable logistic regression.
Results
Overall, 240/1205 participants (19.9%) reported long Covid. Long Covid risk was significantly higher for women OR 1.71 (95% CI: 1.17–2.51), people with comorbidities 2.19 (95% CI: 1.56–3.08) and those using steroid inhalers for Covid‐19 treatment (2.34 [95% CI: 1.29–4.24]). Long‐Covid risk increased with increasing Covid‐19 infection severity (moderately severe symptoms: 2.23 [95% CI: 1.50–3.30], extremely severe symptoms: 5.80 [95% CI: 3.48–9.66], presented to ED/hospitalised: 7.22 [95% CI: 3.06–17.03]). We found no significant difference in the likelihood of long Covid between the Omicron and pre‐Omicron periods, vaccination status and participant age. We identified two long Covid clusters (pauci‐symptomatic, n = 170, vs. polysymptomatic, n = 66). Polysymptomatic cluster membership was associated with worse functioning (impacts on work, moderate activity, emotions and energy). Severity acute infection was strongly predictive of polysymptomatic cluster membership (5.72 [2.04–17.58]). Monoclonal antibody treatment was strongly associated with pauci‐symptomatic cluster membership (0.02 [0.00–0.13]).
Discussion
Our study shows that long Covid is an important health burden in Australia, including during the Omicron era, and identifies several risk factors. We found a subgroup of patients characterised by more symptoms and worse functional outcomes. Our findings can inform policies for protecting vulnerable populations and frameworks for long Covid risk assessment and management.
Conclusions
One‐in‐five people may suffer long Covid after acute Covid‐19 infection, with similar risk across age groups. Omicron variants appear not to have a lower risk compared to earlier variants in our study. A cumulative number of symptoms can help triage long Covid patients. Patient or Public Contribution We did not involve patients or the public in the design of the questionnaire. However, after a soft launch, we revised some survey questions by reviewing early responses from patients and the public.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biosecurity Program, The Kirby Institute, Faculty of Medicine and Health, The University of New South Wales, Sydney, Australia.
- University of Western Australia Medical School, University of Western Australia, Perth, Australia.
- William Harvey Research Institute, Queen Mary University of London, London, UK.
- Health and Social Care Unit, School of Public Health and Preventive Medicine, Monash University in collaboration with Monash Health, Melbourne, Australia.
- College of Public Service & Community Solutions, and College of Health Solutions, Arizona State University, Tempe, Arizona, USA.
ORCID-Profile: Damian Alexander Honeyman, Darshini Ayton, Chandini Raina MacIntyre
Förderung
- E.T., R.C., D.A.H., R.D., M.K., A.N. and D.G. are supported by the Balvi Filantropic Fund. C.R.M. is funded by NHMRC Investigator Grant 2016907. D.A.H. and A.N…
Zitieren
APA
Tawfiq, E., Chen, R., Honeyman, D. A., Dawson, R., Kunasekaran, M., Notaras, A., Gurdasani, D., Skouteris, H., Ayton, D., & MacIntyre, C. R. (2025). Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023. Health Expectations. https://doi.org/10.1111/hex.70273
Vancouver
Tawfiq E, Chen R, Honeyman DA, Dawson R, Kunasekaran M, Notaras A, et al. Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023. Health Expectations. 2025. doi:10.1111/hex.70273
BibTeX
@article{Tawfiq2025,
author = {Tawfiq, Essa and Chen, Rosalie and Honeyman, Damian Alexander and Dawson, Rebecca and Kunasekaran, Mohana and Notaras, Adriana and Gurdasani, Deepti and Skouteris, Helen and Ayton, Darshini and MacIntyre, Chandini Raina},
title = {Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023},
journal = {Health Expectations},
year = {2025},
doi = {10.1111/hex.70273}
}
EUVIMED